DF/HCC General Contact and Office Information

Jeffrey Meyerhardt, MD
Associate Director for Clinical Research, DF/HCC

Clinical Research Support Offices

Clinical Research Agreements Office
Director: Mary Melloni, RN, JD, MBA
The Clinical Research Agreements Office works with industry to negotiate budgets and contracts for PI-initiated trials. For BCH and BIDMC-led trials, the Office works closely with clinical trials negotiators at their respective institutions.

Clinical Trials Business Office (CTBO)
Director: James Huse
The CTBO provides a centralized, comprehensive program of support for sponsored clinical research. Offices at lead sites work with principal investigators and their teams to evaluate budgetary and financial implications for new studies. The CTBO also prepares and negotiates financial terms with industry sponsors; and manages post-award finances including invoices, accounts receivable, funds, distributions, and financial reports.

Office for Human Research Studies (OHRS)
Director: Sarah Kiskaddon
The Office for Human Research Studies (OHRS) oversees the scientific and Institutional Review Board review processes for all cancer relevant research conducted by the five Harvard clinical institutions under the umbrella of Dana-Farber/Harvard Cancer Center. 

Office of Data Quality (ODQ)
Senior Director: Nicholas Farley
The Office of Data Quality focuses on quality assurance, quality control, and quality improvement processes for the DF/HCC.  The office is responsible for clinical trials auditing, data safety monitoring, and overall data quality, as required by the Cancer Center Support Grant. 

Research Informatics Operations (RIO)
Director: Erica Woulf, MBA
RIO supports the growing technological needs of the clinical trials research community.  The office provides a collaborative, responsive, integrated and focused approach to all aspects of research systems development and support.  

Massachusetts General Hospital Cancer Center Protocol Office (MGH CCPO)
Administrative Director: Robert Herman
The Cancer Center Protocol Office (CCPO) provides centralized data management and administrative management for therapeutic oncology clinical trials conducted within the Massachusetts General Hospital Cancer Center.  

Dana-Farber Cancer Institute Clinical Trials Office
Directors: Anne Daoust
The Clinical Trials Office supports DFCI disease programs and develops policies, procedures, and best practices related to clinical trials; coordinates submission and compliance; assists in the pre-review of protocols before submission for approval; and facilitates clinical research staff recruitment, onboarding and training. 

Beth Israel Deaconess Medical Center Cancer Clinical Trials Office (BIDMC CCTO)
Interim Director: Michele Vincitore
The Cancer Clinical Trials Office (CCTO) at Beth Israel Deaconess Medical Center (BIDMC) supports clinical research and provides infrastructure and services to the BIDMC cancer disease programs.